Yüklüyor......
In-depth plasma proteomics reveals increase in circulating PD-1 during anti-PD-1 immunotherapy in patients with metastatic cutaneous melanoma
BACKGROUND: Immune checkpoint inhibitors (ICIs) have significantly improved the outcome in metastatic cutaneous melanoma (CM). However, therapy response is limited to subgroups of patients and clinically useful predictive biomarkers are lacking. METHODS: To discover treatment-related systemic change...
Kaydedildi:
| Yayımlandı: | J Immunother Cancer |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BMJ Publishing Group
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7253007/ https://ncbi.nlm.nih.gov/pubmed/32457125 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2019-000204 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|